Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/29417
Title: The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
Authors: Aloj, L
Attili, B
Lau, D
Caraco, C
Lechermann, LM
Mendichovszky, IA
Harper, I
Cheow, H
Casey, RT
Sala, E
Gilbert, FJ
Gallagher, FA
Keywords: receptors;cell membrane proteins;positron emission tomography;targeted radionuclide therapy;radiopharmaceutical development
Issue Date: 12-Jun-2020
Publisher: Elsevier
Citation: Aloj, L. et al. (2021) 'The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy', Nuclear Medicine and Biology, 92, pp. 53 - 64. doi: 10.1016/j.nucmedbio.2020.06.005.
Abstract: Targeting specific cell membrane markers for both diagnostic imaging and radionuclide therapy is a rapidly evolving field in cancer research. Some of these applications have now found a role in routine clinical practice and have been shown to have a significant impact on patient management. Several molecular targets are being investigated in ongoing clinical trials and show promise for future implementation. Advancements in molecular biology have facilitated the identification of new cancer-specific targets for radiopharmaceutical development.
URI: https://bura.brunel.ac.uk/handle/2438/29417
DOI: https://doi.org/10.1016/j.nucmedbio.2020.06.005
ISSN: 0969-8051
Other Identifiers: ORCiD: Luigi Aloj https://orcid.org/0000-0002-7452-4961
ORCiD: Ai Hui Doreen Lau https://orcid.org/0000-0002-7623-2401
ORCiD: Laura Lechermann https://orcid.org/0000-0002-2742-6269
ORCiD: Evis Sala https://orcid.org/0000-0002-5518-9360
ORCiD: Fiona Gilbert https://orcid.org/0000-0002-0124-9962
ORCiD: Ferdia Gallagher https://orcid.org/0000-0003-4784-5230
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2020 Elsevier. All rights reserved. This manuscript version is made available under the Creative Commons (CC-BY-NC-ND 4.0) Attribution-NonCommercial-NoDerivatives 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/), see: https://www.elsevier.com/about/policies/sharing.768.21 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons